Literature DB >> 10516042

The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro.

J R Creson1, A A Lin, Q Li, D F Broad, M R Roberts, S J Anderson.   

Abstract

We have investigated the ability of anti-CD28 antibody costimulation to induce resistance to macrophage (M)-tropic strains of human immunodeficiency virus type 1 (HIV-1) in vitro. Our results confirm the observations of Levine et al. (15) that stimulation of CD4 T cells with anti-CD3/anti-CD28 antibodies coimmobilized on magnetic beads renders the cells resistant to infection by M-tropic strains of HIV-1. The resistance was strongest when the beads were left in the cultures throughout the experiment. In contrast, stimulation of CD4 T cells with the same antibodies immobilized on the surface of plastic culture dishes failed to induce resistance and resulted in high levels of p24 production. This was true even if the cells were passaged continuously on freshly coated plates. If the beads were removed after initial stimulation, p24 production increased over time and produced a result intermediate to the other forms of stimulation. For beads-in, beads-out, and one-time plate stimulated cultures, resistance to infection correlated with down-regulation of CCR5 expression at the cell surface and with increased production of beta-chemokines. However, cultures of CD4 T cells continuously passaged on anti-CD3/anti-CD28-coated plates produced large amounts of p24 despite decreased levels of CCR5 expression and increasing production of beta-chemokines. Expression of the T-cell activation markers CD25 and CD69 and production of gamma interferon further supported the differences in plate versus bead stimulation. Our results explain the apparent contradiction between the ability of anti-CD28 antibody costimulation to induce resistance to HIV infection when presented on magnetic beads and the increased ability to recover virus from the cells of HIV-positive donors who are on highly active antiretroviral therapy when cells are stimulated by anti-CD3/anti-CD28 immobilized on plastic dishes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516042      PMCID: PMC112968     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Differential effects of CD28 costimulation on HIV production by CD4+ cells.

Authors:  E Barker; K N Bossart; J A Levy
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

2.  Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

Authors:  B L Levine; W B Bernstein; M Connors; N Craighead; T Lindsten; C B Thompson; C H June
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 3.  The human interleukin-2 receptor.

Authors:  W C Greene; W J Leonard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

4.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C.

Authors:  R Testi; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

5.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

6.  Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation.

Authors:  J L Riley; R G Carroll; B L Levine; W Bernstein; D C St Louis; O S Weislow; C H June
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

7.  CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

Authors:  J A Ledbetter; J B Imboden; G L Schieven; L S Grosmaire; P S Rabinovitch; T Lindsten; C B Thompson; C H June
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.

Authors:  B L Levine; Y Ueda; N Craighead; M L Huang; C H June
Journal:  Int Immunol       Date:  1995-06       Impact factor: 4.823

Review 10.  The B7 and CD28 receptor families.

Authors:  C H June; J A Bluestone; L M Nadler; C B Thompson
Journal:  Immunol Today       Date:  1994-07
View more
  10 in total

1.  Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

Authors:  M Mengozzi; M Malipatlolla; S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.

Authors:  Becky Schweighardt; Ann-Marie Roy; Duncan A Meiklejohn; Edward J Grace; Walter J Moretto; Jonas J Heymann; Douglas F Nixon
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms.

Authors:  Belén Blanco; M Carmen Herrero-Sánchez; Concepción Rodríguez-Serrano; Mercedes Sánchez-Barba; M Consuelo Del Cañizo
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

4.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.

Authors:  Lamorris M Loftin; Martha F Kienzle; Yanjie Yi; Benhur Lee; Fang-Hua Lee; Lachlan Gray; Paul R Gorry; Ronald G Collman
Journal:  Virology       Date:  2010-04-09       Impact factor: 3.616

6.  Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.

Authors:  Max W Richardson; Richard G Carroll; Matthew Stremlau; Nikolay Korokhov; Laurent M Humeau; Guido Silvestri; Joseph Sodroski; James L Riley
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Authors:  Max W Richardson; Julie Jadlowsky; Chuka A Didigu; Robert W Doms; James L Riley
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

8.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

9.  Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processes.

Authors:  Wen-Wen Xu; Miao-Jun Han; Dai Chen; Ling Chen; Yan Guo; Andrew Willden; Di-Qiu Liu; Hua-Tang Zhang
Journal:  BMC Med Genomics       Date:  2013-05-01       Impact factor: 3.063

10.  HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells.

Authors:  Paula C Soto; Valeri H Terry; Mary K Lewinski; Savitha Deshmukh; Nadejda Beliakova-Bethell; Celsa A Spina
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.